Abstract

Cellular metabolism is a key regulator of energetics, cell growth, regeneration, and homeostasis. Spatially mapping the heterogeneity of cellular metabolic activity is of great importance for unraveling the overall cell and tissue health. In this regard, imaging the endogenous metabolic cofactors, nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and flavin adenine dinucleotide (FAD), with subcellular resolution and in a noninvasive manner would be useful to determine tissue and cell viability in a clinical environment, but practical use is limited by current imaging techniques. In this paper, we demonstrate the use of phasor-based hyperspectral light-sheet (HS-LS) microscopy using a single UVA excitation wavelength as a route to mapping metabolism in three dimensions. We show that excitation solely at a UVA wavelength of 375 nm can simultaneously excite NAD(P)H and FAD autofluorescence, while their relative contributions can be readily quantified using a hardware-based spectral phasor analysis. We demonstrate the potential of our HS-LS system by capturing dynamic changes in metabolic activity during preimplantation embryo development. To validate our approach, we delineate metabolic changes during preimplantation embryo development from volumetric maps of metabolic activity. Importantly, our approach overcomes the need for multiple excitation wavelengths, two-photon imaging, or significant postprocessing of data, paving the way toward clinical translation, such as in situ, noninvasive assessment of embryo viability.
Keywords: light-sheet, autofluorescence, label-free imaging, embryology
Introduction
Metabolism is central to fulfilling the biological functions of living cells, underpinning key processes in development, regeneration, and homeostasis.1 The quantification of metabolic activity has, therefore, been an important endeavor to gain insight into live cell and tissue health. This has been accelerated by recent findings that have highlighted its potential as a diagnostic marker for cancer2−5 and neurodegenerative disease.6,7 Furthermore, metabolic activity has been shown to be a reliable indicator of treatment efficacy in cancer organoids8,9 and an indicator of viability in tissue engineering10,11 and for the developing embryo.12−14 Advances in photonics have been at the forefront of research in cellular metabolism because they offer a route to monitor metabolic activity in situ via fluorescence. To date, many volumetric imaging techniques with subcellular resolution have been restricted to use solely in a research capacity. This is because they fail to meet the imaging speed and permissible phototoxicity required for many clinical applications. Furthermore, they are often inaccessible outside a research environment due to the complexity, availability, and cost of the required instrumentation equipment.15 Enabling adoption for routine biological and clinical assessment requires the development of noninvasive, high-resolution label-free imaging techniques with minimal technical complexity. A powerful example of this demand can be found in clinical in vitro fertilization (IVF) procedures, where metabolic activity can reveal embryos with higher developmental potential.16 Noninvasive optical imaging techniques have the potential to improve embryo selection and revitalize the presently stagnant 30% success rate of live birth.17,18
Cellular metabolic activity can be quantified noninvasively by monitoring autofluorescence from endogenous metabolic coenzymes nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and flavin adenine dinucleotide (FAD). A common metric to quantify metabolism is the redox ratio (RR), which may be defined as the normalized ratio of the molecular concentrations of the two metabolites.19 Ratiometric quantification of both metabolites has been assessed spatially using several imaging modalities, such as epifluorescence microscopy,14 confocal microscopy,20,21 multiphoton microscopy,22 and fluorescence lifetime imaging microscopy (FLIM).2 The major challenge of all of these modalities is the accurate unmixing and quantification of the fluorescent species. The conventional way to address this challenge is to employ multiple excitation wavelengths and then collect the emission from each metabolite, NAD(P)H and FAD, using carefully selected bandpass filters.23 This approach has enabled the assessment of metabolic activity in numerous pathological conditions including cancer2−5 and neurological diseases.6,7
Some recent efforts have been made to quantify metabolic activity using light-sheet microscopy (LSM). LSM is a powerful volumetric, rapid imaging modality with submicron resolution that is well known for its minimal photodamage due to its geometry and fast image acquisition.24 In this regard, LSM contrasts with other imaging modes, such as FLIM, which have long integration times25 that impede their use for high-throughput viability screening and long-term volumetric metabolic imaging. There have been two recent studies based on light-sheet microscopy for metabolic imaging. Favreau et al.26 sequentially excite NAD(P)H and FAD metabolic coenzymes using two wavelengths of 405 and 488 nm, respectively, to assess the response of colorectal cancer organoids to treatments. Dual-wavelength excitation requires precise coalignment of the illumination beams, and the inherent longitudinal chromatic aberration and dispersion may lead to disparate fields of view and focal positions for each wavelength. Spatial artifacts in RR assessment may also arise from differences in scattering and absorption properties between the two wavelengths as a function of depth. Furthermore, the subsequent impact of the difference in laser power at the two wavelengths and detector sensitivity for two collection channels on the fluorescence intensity levels collected for NAD(P)H and FAD typically requires correction in a postprocessing step via rigorous calibration using reference solutions. Recently, Hedde et al.27 demonstrated that two-photon LSM at 740 nm coupled with a new hyperspectral detection scheme can distinguish a variation in the metabolic RR between the crypt and lumen of a mouse colon. While promising, multiphoton LSM requires a costly and high-pulse-energy laser source and thus is not readily compatible with a clinical setting.
In contrast to these studies, we present a light-sheet microscopy system that employs single-wavelength, one-photon excitation in the UVA range at 375 nm. Single-wavelength excitation is enabled by the sensitive hardware-based unmixing for accurate, fast metabolic mapping in all three dimensions and without additional calibration steps. Our study reveals both numerically and experimentally that, in the case of NAD(P)H and FAD coexcitation, performing standard bandpass filtering of the emission spectra fails to accurately quantify RR, which has been a major limitation of single-wavelength excitation. This is further complicated by the lack of standardized bandpass filters, which prevents a direct comparison between studies. To circumvent this issue, here we adopt a hardware-based spectral phasor analysis of fluorescence27 to quantify RR by the sole use of two cosine and sine transmission filters in our LSM approach.
We demonstrate the utility of our approach by performing metabolic imaging of preimplantation embryos, which is a burgeoning need in clinical embryology.13 We clearly delineate changes in metabolic state within key stages of embryo development from the 2-cell up to the blastocyst-stage. Mapping metabolic activity in a volume with minimal photodamage is necessary to capture embryo-level metabolic heterogeneity, which is known to be crucial in the case of embryos with cells containing an unexpected number of chromosomes (mosaicism).14 Collectively, we propose that our rapid 3D imaging technique offers minimal technical complexity and can capture metabolic activity, opening up new opportunities for the rapid, high-throughput metabolic mapping of 3D samples in clinical contexts.
Results and Discussion
The key challenge of single-wavelength excitation for RR monitoring is the ability to coexcite NAD(P)H and FAD fluorophores while unmixing their relative contributions to the total emitted intensity with high sensitivity. Several definitions of RR are generally proposed in the literature, and we adopt here the convention where RR is defined as the ratio of FAD intensity divided by the sum of NAD(P)H and FAD intensities, as follows: IFAD/(INAD(P)H + IFAD).19 Importantly, this parameterization of RR demands that the recorded intensities reflect the underlying concentration of the metabolic coenzymes. Thus, it is imperative that the product of the molar absorbance, quantum yield, and integrated probability density of each metabolite, as well as the detection efficiency of the imaging method, is relatively equivalent for NAD(P)H and FAD, as detailed in the Section S1 of the Supporting Information. While most of these factors are intrinsic properties of the fluorophores or the setup and cannot be tuned, the absorbance depends on the wavelength used for the excitation and therefore needs to be carefully selected. Figure 1a shows that one-photon NAD(P)H fluorescence absorption and emission maxima are approximately at 350 and 460 nm, respectively, while one-photon FAD fluorescence absorption maxima can be found at 350 and 450 nm, with a fluorescent emission maximum at 535 nm, as reported in the literature.28,29 In this regard, the illumination wavelength is a key parameter that can be adjusted to achieve the desired equivalence in the NAD(P)H and FAD absorbance. An absorbance of the same magnitude for NAD(P)H and FAD can be obtained with an illumination in the UVA range (315–400 nm), which ensures an approximate linearity between RR and coenzyme concentration (derived in detail in Section S1 of the Supporting Information).
Figure 1.
(a) Absorption (dashed line) and emission (solid line) spectra of NAD(P)H (blue) and FAD (green) metabolites reported in28,29 with additional markers for λexc values of 375, 405, and 488 nm. (b) Representative intensity images of mouse embryos collected in the channel Ch1 (447/60 nm) and Ch2 (560/94 nm) using 375, 405, and 488 nm excitations. (c) Open-top light-sheet configuration. The sample is placed on a custom-designed V-mount. This is illuminated from the right through the illuminating objective (obj1) and fluorescent light is collected by the detecting objective (obj2) before passing through the detection path shown in (d). (d) Schematic of the hyperspectral detection where fluorescence signals are converted to non-normalized phasor coordinates (G, S) using cosine/sine transmission filters. (e) Comparison between the RR evaluated using spectral phasor-based detection (purple) and bandpass filters (gray).
To understand how the choice of the excitation wavelength translates in terms of intensity contrast, we imaged mouse embryos and compared the contrast obtained in two spectral channels with different bandpass filters (Ch1:447/60 nm; Ch2:560/94 nm) and with illuminations at 375, 405, and 488 nm (see Figure 1b). Unsurprisingly, excitation at 488 nm provides contrast only in Ch2 (commensurate with FAD emission) with clear visualization of bright domains within the cells, likely due to the presence of enriched FAD within mitochondria.30 In comparison, excitation at 405 nm provides a low, yet relatively uniform, contrast in Ch1 and a high and moderately uniform contrast in Ch2. This can be understood as a coexcitation of NAD(P)H and FAD, with the total intensity dominated by FAD fluorescence along with a small contribution from NAD(P)H leaking in Ch2. Lastly, excitation at 375 nm provides higher contrast in Ch1 compared to previous excitations, indicating higher NAD(P)H intensity, while FAD is coexcited. Therefore, to coexcite FAD and NAD(P)H simultaneously, we use a continuous laser source at 375 nm, which is an easily accessible source. Notably, UV excitation has been used in early spectroscopy studies to isolate NAD(P)H contribution,20 as well as in recent studies for NAD(P)H and FAD coexcitation using an illumination wavelength of 375 nm.31,32 However, it was rarely used for imaging due to the lack of excitation confinement of common one-photon fluorescence imaging techniques (as in confocal microscopy), thus leading to potential photodamage caused by high light doses and long exposure times.
Based on this wavelength selection, we experimentally
assessed
metabolic activity in mouse embryos using a custom-built open-top
light-sheet geometry with Gaussian-beam illumination, as illustrated
in Figure 1c. Full
details of the experimental setup can be found in Figure S2 of the Supporting Information and in the Methods. We incorporated two spectral detection schemes, namely:
(i) a set of bandpass filters, and (ii) filters with specific sine/cosine
transmission following a phasor-based hyperspectral detection method
proposed by Hedde et al.27 (see Figure 1d). The spectral
phasor analysis was originally introduced by Fereidouni et al.33 to provide a fit-free analysis of spectral data.
This consists of a postprocessing step that transforms the fluorescence
spectra into their nth order Fourier spectral components:
and
, where Δλ = λmax – λmin. Gn and Sn can be
represented as orthogonal components on a phasor plot. For simplicity,
spectral analysis can be limited to the 1st Fourier order (n = 1), which describes the spectral barycenter of the emission.
The phasor-based hyperspectral approach is based on the addition of
two spectral filters into the detection path with Tcos(λ) and Tsin(λ)
transmission profiles that follow a single cosine and sine period,
respectively, in the 400–700 nm wavelength range. Each filter
converts the sample-emitted fluorescent light directly into the Fourier
components G and S, which are sequentially projected onto the camera
by means of a tube lens in our setup (Figure 1d). We remark that the use of the term “hyperspectral”
to describe this technique differs from its more common usage where
a continuous finely resolved spectrum is obtained for each pixel of
an image. However, we use the term to remain consistent with existing
literature on the phasor-based hyperspectral method.
The quantification
of RR values is a typical challenge in the case
of coenzyme coexcitation. The common approach to estimate RR values
is to use two bandpass filters with bandwidths centered on the maxima
of NAD(P)H and FAD emission, i.e.:
, where Ch1 collects photons in
the channel
centered at 450 nm and Ch2 detects photons in the channel centered
at 550 nm sequentially from two separate excitation wavelengths. For
a clear comparison, we investigate the use of this “gold-standard”
approach in the single-wavelength excitation regime. Figure 1e shows the RRa values derived numerically from the normalized emission
spectra of mixed solutions of NAD(P)H and FAD with a linear dilution
coefficient. When using single-wavelength excitation, RRa values were found to increase from around 0.5 to
1 for filters with bandwidths of 30 and 80 nm when the dilution coefficient
varied from 0% (NAD(P)H only) to 100% (FAD only). This large discrepancy
between RRa values compared
to the expected values—which should vary between 0 and 1 for
a similar distribution of the dilution coefficient—is due to
the cross-talk between NAD(P)H and FAD in the collected channels.
As a result, a substantial contribution of NAD(P)H fluorescence in
the FAD detection channel translates to an incorrect parametrization:
, where the subscript denotes the channel
in which the fluorescence is collected.
Next, we compared numerical
RR values quantified with the conventional
method with the values resulting from the spectral phasor analysis. Figure 1d shows the spectral
phasor coordinates of the solutions under study. An interesting property
of this approach, known as the linear addition law, dictates that
mixed contributions lie linearly along a line that joins the coordinates
of the pure fluorescent species. As derived in detail in Section S2
in the Supporting Information, RR can be
calculated as
, i.e., the distance between the NAD(P)H
coordinate and any projected coordinate normalized by the distance
between the NAD(P)H-FAD coordinates. Figure 1e illustrates that, in contrast to RR values
assessed for bandpass filters, RRb values do not suffer
from cross-talk and accurately represent the mixing ratio from 0 and
100%. As noted above, the RR evaluated with the hyperspectral approach
provides a value that accurately estimates
and offers a clear advantage
by providing
an accurate RR value consistent with the original definition. In addition,
the precision of both methods was also investigated in Section S1
of the Supporting Information by calculating
the ratio of the normalized RR standard deviation to the RR gradient.
The precision of the spectral phasor analysis was found to be superior
to that of conventional bandpass detection. It is also worth noting
that for wide spectral bandpass filters, the precision approaches
that of spectral phasor analyses due to the larger number of photons
collected. In Section S1 of the Supporting Information, we have further explored the effect of non-normalization for pure
solutions intensities, which can occur when the two absorbances associated
with the illumination wavelength are not of the same order of magnitude.
As a result, we observe a loss of linearity in RR values along the
trajectory; however, the hyperspectral method remains superior to
bandpass filters.
Figure 2a–g illustrates the recovery of metabolic information on a single cross-sectional plane of a blastocyst-stage embryo. The imaged intensities, corresponding to phasor coordinates (G,S), were background corrected and normalized for each pixel (see the Methods section for details). Since any change in embryo metabolism is likely to result in a translation in the phasor coordinates along the NAD(P)H-FAD trajectory, the phasor coordinates of pure NAD(P)H and FAD solutions were experimentally characterized (Figure 2a), and then phasor coordinates in each pixel of the image were orthogonally projected along the NAD(P)H-FAD trajectory (Figure 2b). For visualization, RRb has been color coded using the color bar shown in Figure 2c. Figure 2d–f shows the total autofluorescence intensity, the phasor plot of all pixels, and the distribution of RRb in the embryo, respectively. The distribution of the RRb data along the NAD(P)H-FAD trajectory was further summarized as a histogram (Figure 2c,g).
Figure 2.
Phasor plots with (a) experimentally measured coordinates of pure NAD(P)H and FAD solutions, (b) RR assessment method based on orthogonal projection of the normalized phasor coordinates (G, S) along the NAD(P)H-FAD trajectory, and (c) the color map encoding RR values for the metabolic maps. Examples of (d) autofluorescence intensity map, (e) phasor coordinates represented on a polar plot, (f) metabolic map, and (g) histogram plot generated by the data analysis pipeline applied on a single imaged plane acquired on a blastocyst-stage embryo. (h) Schematic representation of 2-, 4-, 8-cell, morula, and blastocyst-stage embryos with their corresponding autofluorescence intensity images and metabolic map. ICM and TE depict the subpopulation of cells—inner cell mass and trophectoderm respectively—found within a blastocyst-stage embryo.
Using our approach, we analyzed 2D and 3D hyperspectral acquisitions of embryos during preimplantation development. Figure 2h presents the autofluorescence intensity and the corresponding metabolic maps of a single cross-section acquired at different embryo developmental stages from the 2-cell up to the blastocyst-stage. The intensity contrast reveals the morphological evolution of an embryo over time. The 2-cell embryo undergoes cellular division (mitosis), which ultimately transforms it into a densely packed cluster of cells (successively 4-cell, 8-cell, and morula). Subsequently, this population of cells undergoes cellular differentiation where pluripotent embryonic cells within an embryo commit to forming either the inner cell mass (ICM, fetal-lineage) or the trophectoderm (TE, placental-lineage) following the formation of a fluid-filled cavity known as the blastocoel cavity. The colorimetric changes in the metabolic maps suggest the possibility of using metabolic variations over time for monitoring embryo development, which we further study and discuss below.
Figure 3 shows examples of 3D visualizations of the morphological and metabolic content of embryos with three side views at the 4-cell (Figure 3a), morula (Figure 3b), and blastocyst-stage (Figure 3c). In addition, we present a 3D movie that represents a metabolic map of these embryos in the Supporting Information. Interestingly, the metabolic map shows heterogeneity throughout the embryos, with higher RRs confined to small domains which are likely to be cells with active mitochondria. This highlights the potential for 3D reconstruction to be used in further studies to conjointly investigate morphological and metabolic properties.
Figure 3.
3D reconstruction of embryo metabolic maps. Gray schematic diagrams depict the aspect of embryos in (a) a 4-cell embryo, (b) a morula, and (c) a blastocyst-stage embryo. XY, XZ, and YZ views along with 3D reconstruction of the metabolic maps are shown for these different stages of development. Scale bar = 20 μm.
To assess the safety of UV exposure, illuminated embryos were returned to the incubator immediately following imaging. The ability of the imaged embryos to complete preimplantation development (blastocyst-stage) was assessed and compared to nonilluminated (control) embryos, which were treated in the same manner but kept in the dark. We found no statistical difference in the number of embryos reaching the blastocyst-stage between the two groups. Interestingly, the developing preimplantation embryo is highly susceptible to perturbations in culture conditions including light exposure.34 In fact, failure to complete preimplantation development is used as a gold standard in assessing toxicity.35 The illumination levels used here (see Section S3 in Supporting Information) did not negatively impact embryo development and thus demonstrate the potential for the use of light-sheet imaging operating at 375 nm for diverse biological materials in future studies.
Finally, we investigated the capability to quantify changes in metabolic activity during development. This was achieved with a 3D analysis of imaging data acquired on embryos throughout development. The mean RR was determined by averaging RR over all pixels of the XYZ image stack generated for each embryo. Further, we have acquired RR values using the conventional method using bandpass filters during the same experiment for comparison, i.e., RRa = ICh2/(ICh1 + ICh2). Figure 4a,b shows the temporal evolution of the two metabolic variables obtained with both methods.
Figure 4.
RR computed following volumetric imaging of embryos through development. Embryos were excited with a 375 nm laser and signals collected via (a) conventional method with 2 bandpass filters and (b) hyperspectral detection. Data are presented as mean ± SEM, n = 11–26 embryos per developmental stage, from 3 independent experimental replicates. Data were analyzed using the Kruskal–Wallis test with Dunn’s multiple comparisons test. Different superscripts indicate statistical significance (P < 0.05) between developmental stages. (c) Correlation graph between RR values assessed using conventional and hyperspectral detection.
It is clear that the range of RR values obtained with bandpass filtering differs from the one using the phasor-based approach, with RRa found to be between 0.51 and 0.57 and RRb values found to be between 0.06 and 0.21, respectively. This discrepancy is predicted and discussed in Figure 1e and manifests due to the cross-talk of coexcited NAD(P)H and FAD emission spectra in the detection channels. This results in a lack of accuracy in the RRa assessment with the bandpass filter approach, leading to an overestimation of the RR.
In addition, the conventional approach does not show statistically significant variations during early embryo development (Figure 4a; P > 0.05), with a statistically significant higher RRa value found only for the blastocyst-stage embryos. In comparison, the hyperspectral method showed a gradual and statistically significant increase in RRb values from the 8-cell up to the blastocyst-stage (Figure 4b; P < 0.05) but with no significant changes in RRb at earlier stages of development. The low and statistically unchanged values reported for both metabolic metrics between 2- and 8-cell stages indicate that embryo metabolism remains low in the early stages of preimplantation embryonic development.
The increase in RR consistently observed with these two methods reflects a change in embryo metabolism characterized by higher metabolic activity. This result corroborates the shift from oxidative phosphorylation to glycolysis as reported in the literature,36 which coincides with an increased bioenergetic demand for cellular proliferation and differentiation as well as changes in the bioavailability of energy substrate in its microenvironment.36 Further, we observe a greater precision in assessing metabolic changes using the hyperspectral method throughout development. We see shifts from low to high metabolism as embryos develop, which coincide with the timing of embryonic genome activation, which occurs at the 2- to 4-cell stage in mice37 and the shift in metabolic pathway utilized as mentioned above.
While metabolic studies using volumetric imaging with subcellular resolution have been limited to a research context because of low throughput in terms of imaging speed and permissible photodamage as well as large footprint, we showed here the benefits of UVA single excitation light-sheet microscopy combined with the phasor-based approach for mouse embryos imaging. The use of HS-LS harnesses the intrinsic advantages of light-sheet microscopy, with rapid 3D imaging and minimal sample illumination. Further, single-wavelength one-photon excitation at 375 nm allows NAD(P)H and FAD coexcitation without the need for costly and difficult-to-access sources, enabling further dissemination of this technology. The simplicity of installation is a major asset from an instrumental perspective for a device designed for a clinical environment, unlike multiwavelength instruments. This helps to overcome issues encountered with dual excitation such as coalignment of illumination beams, dissimilar fields of view and focus positions, and spectral properties of the scattering inducing differences in attenuation as a function of the illumination wavelengths.
The facile implementation of a single-wavelength for excitation was made possible by spectral phasor-based filtering, which enabled RR assessment with superior accuracy in the case of NAD(P)H and FAD coexcitation compared to bandpass filter methods. A further advantage of phasor-based detection is the capacity to simultaneously image other spectrally distinct fluorescent species, as illustrated by Hedde et al.27 This would be of benefit to future studies aiming to simultaneously quantify RR and localize other fluorescent labels of interest. In our study, the recorded phasor coordinates lie along the precalibrated RR trajectory, further emphasizing the dominant presence of NAD(P)H and FAD over other autofluorescent species.
Although our study of UVA illumination shows we can excite both NAD(P)H and FAD and lead to a good axial resolution, it can potentially induce phototoxicity and consequent DNA damage as well as reduced penetration depth. The light-sheet configuration is intrinsically effective in minimizing photodamage and phototoxicity due to the confinement of excitation in the illumination plane. The penetration depth with our Gaussian embodiment showed no significant decrease in autofluorescence intensity along the optical axis of the light-sheet, indicating that 80–100 μm samples such as embryos can be imaged. We remark that the field of view and depth penetration of our UVA system could be enhanced significantly if required by the use of an Airy beam in the illumination path,38 thus ensuring that our approach is applicable to a wider range of samples.31,32 As previously reported, the survival rate of imaged embryos was equal to that of unimaged embryos, confirming the low impact of such UV illumination, with embryos being extremely sensitive samples.
Adapting miniaturized light-sheet microscopy39,40 with illumination in the UVA range at 375 nm combined with a phasor-based hyperspectral detection would enable the system to be portable for studies in a clinical environment. Although our initial demonstration is limited to assessing metabolic changes in embryos at different stages of development, this study paves the way for metabolic assessment in mouse embryos to evaluate their viability for implantation in a clinical context. Future studies could consider the transfer of embryos into pseudopregnant female mice following metabolic assessment using HS-LS to assess for potential pregnancy and birth complications associated with exposure to UVA wavelength during preimplantation embryo development. Also, combined with microfluidic devices, this approach promises high-throughput metabolic assessment in a large variety of models ranging from embryos to organoids to evaluate the viability or treatment efficiency.
Conclusions
We have demonstrated a single 375 nm wavelength phasor-based hyperspectral light-sheet microscope for volumetric metabolic mapping. The autofluorescence signals for NAD(P)H and FAD were collected using both conventional detection with two separate bandpass filters and hardware-based hyperspectral detection following excitation at a wavelength of 375 nm. Hyperspectral detection was shown to be more precise and accurate with regard to changes in embryo metabolism throughout development compared to conventional detection of NAD(P)H and FAD signals. This method promises accurate 3D mapping of cellular metabolism, which can benefit areas such as analyses of organoids, cell spheroids, and preimplantation embryos. The facile implementation of this system opens up opportunities for the high-throughput, accessible imaging of embryos to study the temporal evolution of metabolism in clinical environments.
Methods
Setup
Imaging was performed using a custom-built open-top virtual light-sheet microscope with three continuous-wave laser sources emitting in the UVA-visible range (see Section S1 of Supporting Information). The first UVA beam is delivered in free space by a 375 nm laser (Stradus 375-60, Vortran). It is magnified with a first telescope (f1 = 40 mm, f2 = 75 mm) and spatially filtered using a pinhole (ϕ = 30 μm) inserted between the two lenses. The second and third beams originate from a pair of 405 and 488 nm fiber-coupled lasers (Obis FP405LX, FP488LX, OBIS LX/LS Laser Box, Coherent) and are coupled into a single fiber via a combiner (OBIS Galaxy Beam Combiner System, Coherent), then collimated in free space by a f3 = 25 mm lens. To precompensate for any longitudinal chromatic aberration accumulated along the illumination path to the imaging plane, the 405 and 488 nm beams were separated again using a dichroic (D2, DMLP425R, Thorlabs) beam splitter and relayed through 1:1 telescopes (f4 = 50 mm) placed in their respective optical paths, thereby finely correcting for divergence and obtaining similar focal planes. A similar dichroic (D3) beam splitter then recombined the 405 nm beam with the 488 nm beam before a third dichroic beam splitter (D1, FF389-Di01-25 × 36 × 1.5, Semrock) was used to recombine them with the 375 nm laser beam. A 1D rotation galvo mirror (GVS201, Thorlabs) was placed conjugate with the back pupil plane of the water-dipping 10× illumination objective (obj1, UMPLFLN10XW, Olympus) via an expansion telescope (f5 = 50 mm, f6 = 75 mm) to laterally scan the Gaussian beam in the field of view. Both the illumination objective and the 40× collection objective (obj2, CFI Apo NIR 40X W, Nikon) were inserted 45° from the horizontal plane into a custom-made mount to achieve the open-top geometry. The embryos were placed in a custom-built V-shaped holder and isolated from the immersion water of the objectives with an FEP film (50 μm, Adtech). The translation of the sample through the light-sheet was performed by an actuator (M-235, PI Instruments). A f7 = 200 mm lens placed after the collection objective projects the image of the sample onto a camera (Orca Flash 4.0, Hamamatsu). The fluorescent response from the sample was filtered either by two filters with a sine/cosine transmission over the 400–700 nm range (Optoprim) as previously shown for a hyperspectral detection by Hedde et al.27 or by two bandpass filters for a conventional ratiometric detection (FF02-447/60-25, FF01-560/94-25, Semrock) to collect NAD(P)H and FAD fluorescence, respectively. The filters were mounted on a fast filter wheel (FW103H, Thorlabs) to rapidly switch between them. Additional notch filters placed before the filter wheel were also used to block residual laser light scattered at 405 nm (405-13) and 488 nm (488-15) if necessary. A permanent bandpass filter in the 400-700 nm range discards the light scattered at 375 nm while filtering the fluorescence. The resolution of the system is 0.6 μm along the x dimension and 1.3 μm along the z axis (see Section S5 in the Supporting Information for more details on resolution characterization). The synchronization between the lasers, the actuator, the filter wheel, and the camera was achieved using MATLAB software.
Data Acquisition
A total of ∼120 embryos were imaged with ∼10 embryos for each developmental stage per experimental replicate placed in the imaging holder. As only 2 embryos can be imaged simultaneously due to the dimension of the field of view, 5 volumetric acquisitions were performed per imaging session. The data for each imaging stack include approximately 30–40 imaged planes, where each plane was imaged successively with different filters to recover different contrasts: (i) no filter to collect the total intensity, (ii) sine filter, (iii) cosine filter, (iv) Ch1 filter, and (v) Ch2 filter. The average power was 190 μW at the sample plane and the integration time was 100 ms per image.
Data Processing
Data Processing Based on the Phasor Approach
The algorithm to process the metabolic data was developed in MATLAB. The intensity images acquired with no cosine/sine filter (Itotal), the sine (Isine), and cosine (Icosine) filters, were first corrected from the background introduced by the ambient light in the lab room and the camera noise. The background references were chosen as the set of images from the first plane of the stack where the embryo is not visible in the field of the camera. Due to the use of different filters which may affect the background intensity detected by the camera, we decided to correct each image of the stack by the image from the first plane acquired with the same filter, i.e., image i of the first plane to image i of plane N. Isine and Icosine images were then corrected by Itotal images so that they range from −1 to 1 using the following formula:
![]() |
Data were then resized by a factor of 0.5 using bilinear interpolation. A region of interest around each individual embryo was manually selected from the image stack for further analysis. To consider only pixels containing relevant spectral information, we excluded pixels with intensities below a certain intensity threshold and then used the MATLAB imerode and imdilate operations to eliminate isolated pixels. The data were then plotted on a phase diagram using the histogram2 function. The pair (Icosine,corrected and Isine,corrected) provided the abscissa and the ordinate coordinates, or equivalently (Imodulus, Iangle) for the modulus and the angular coordinates. We refer the reader to Section S6 in the Supporting Information for a flowchart illustrating the data processing steps described below.
Definition of an RR for the Hyperspectral Approach
To assess changes in metabolic activity, we defined a metric by projecting the phasor coordinates of each image pixel along the axis joining the phasor coordinates of pure NAD(P)H and FAD species measured experimentally with the following formula:
![]() |
1 |
Then, we calculated the relative contribution of the two metabolites in each pixel via the ratio:
![]() |
This value was encoded for each embryo.
The statistical study was performed by summing the histograms of RR data calculated for each imaged plane to extract a mean RR value for each embryo. The graphs presented in Figure 4a describe the average values thus extracted for each embryo.
Definition of an RR for the Conventional Approach
To
provide another metric against which to compare the previous one,
we estimated the RR via the conventional approach with bandpass filters.
RR is derived from the following calculation:
where ICh1 is
the intensity collected through the 447/60 filter and ICh2 is the intensity collected through the 560/94 filter.
Similar to the hyperspectral approach, the average value of the RR
histograms summed over all of the imaged planes was extracted for
every embryo.
3D Reconstruction of Hyperspectral Data
For the 3D reconstructions, a median filter was applied over three pixels to smooth the RR data. As the sample scan is performed along an axis tilted at 45° from the light-sheet axis, the recorded images and the RR data were transformed using affinity transformation into physical coordinates. A linear interpolation (MATLAB interp2) was then performed on the intensity and RR volumes along the detection axis to achieve an isotropic pixel size. The two stacks were then centered and cropped to a cubic volume of the same size for all embryos. A mask was built from the intensity information, smoothed using a Gaussian function, and then applied to the RR stack to remove low-intensity pixels. Finally, RR values between −0.5 and 1 were encoded using a custom color map, and IMARIS (Oxford Instruments, UK) software was used to obtain volumetric visualizations.
Culture Medium Preparation
All embryo culture took place in media overlaid with paraffin oil (Merck Group, Darmstadt, Germany) at 37 °C in a humidified incubator set at 5% O2 and 6% CO2 balanced in N2. Culture dishes were pre-equilibrated for at least 4 h prior to use. All handling procedures were performed on microscopes fitted with heating stages calibrated to maintain media in dishes at 37 °C. All culture media were supplemented with 4 mg/mL low fatty acid bovine serum albumin (BSA, MP Biomedicals, AlbumiNZ, Auckland, NZ) unless specified otherwise. Oviducts were collected in filtered Research Wash medium (ART Lab Solutions, SA, Australia) and embryos were cultured in filtered Research Cleave medium (ART Lab Solutions, SA, Australia).
Embryo Preparation
Female (21–23 days) CBA x C57BL/6 first filial (CBAF1) generation mice were obtained from Laboratory Animal Services (University of Adelaide, Australia) and maintained on a 12 h light: 12 h dark cycle with rodent chow and water provided ad libitum. Animal ethics were approved by the School of Biology Ethics Committee of the University of St. Andrews (SEC20001) and the Animal Ethics Committee of the University of Adelaide (M-2019-097). Embryo collection was conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Female mice were administered intraperitoneally (i.p.) with 5 IU of equine chorionic gonadotropin (eCG; Folligon, Braeside, VIC, Australia), followed by 5 IU human chorionic gonadotrophin (hCG, i.p.; Kilsyth, VIC, Australia) 46 h later. Female mice were then mated overnight with male mice of proven fertility. At 47 h post-hCG, females were culled by cervical dislocation, and the oviducts were carefully dissected to isolate 2-cell embryos. Two-cell embryos were released from the oviducts by gently flushing the oviduct using prewarmed Research Wash medium (ART Lab Solutions, SA, Australia) supplemented with 4 mg/mL low fatty acid bovine serum albumin (BSA, MP Biomedicals, AlbumiNZ, Auckland, NZ) using a 29-gauge insulin syringe with needle (Terumo Australia Pty Ltd., Australia) and subsequently underwent embryo vitrification.
Embryo Vitrification and Warming
Media used for embryo vitrification and warming were as described in Tan et al.14 In brief, two-cell embryos were vitrified with the Cryologic vitrification method, consisting of timely, sequential washes in handling medium followed by 3 min in equilibration solution and 30 s in vitrification solution, prior to loading onto a Fiberplug straw for storage in liquid nitrogen. For embryo warming, Fiberplugs containing embryos were removed from liquid nitrogen and quickly submerged into a handling medium supplemented with 0.3 M sucrose, followed by sequential washes in handling media with decreasing concentrations of sucrose (0.25, 0.15, and 0 M) for 5 min each. The postwarming survival rate was above 90% for all groups (data not shown). Warmed 2-cell embryos were then cultured in Research Cleave medium supplemented with 4 mg/mL BSA and allowed to develop up until the blastocyst-stage.
Sample Preparation for Imaging
For imaging, 2-, 4-, 8-cell, morula, and blastocyst-stage embryos were collected at 6-, 10-, 24-, 30-, and 48 h postwarming, respectively, and were transferred into prewarmed 20 μL drops of Research Wash medium supplemented with 4 mg/mL BSA in a specialized printed chamber overlaid with an FEP film and covered with paraffin oil. The Research Wash medium provides a physiologically pH-buffered medium for live embryo imaging. A maximum of 10 embryos per sample holder was used for imaging. Embryos were maintained at 37 °C throughout the imaging process by heating the immersion water by means of two cartridges inserted in the support. The regulation of the voltage applied to the cartridges to keep the temperature constant is achieved with a PID controller.
Acknowledgments
The authors would like to thank Mark Robertson for designing and building the objective support, Christopher Booth for designing and installing the sample mount heating system, and Juan Varela for providing the Imaris software.
Data Availability Statement
The research data supporting this publication can be accessed at https://doi.org/10.17630/48ce8571-38bd-4c53-845a-5cfa2b89aa3a.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsphotonics.3c00900.
This work was supported by funding from the UK Engineering and Physical Sciences Research Council (EP/P030017/1, EP/R004854/1), the Australian Research Council (FL210100099), the National Health and Medical Research Council (APP2003786), and the European Union’s Horizon 2020 research and innovation program under the H2020 FETOPEN project “Dynamic” (EC-GA 863203) and “Proscope” (871212). K.R.D is supported by a Hospital Research Foundation Fellowship (Midcareer fellowship C-MCF-58-2019) and a Future Making Fellowship (University of Adelaide).
The authors declare no competing financial interest.
Supplementary Material
References
- Jones D. P.; Sies H. The redox code. Antioxid. Redox Signaling 2015, 23, 734–746. 10.1089/ars.2015.6247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skala M. C.; Riching K. M.; Gendron-Fitzpatrick A.; Eickhoff J.; Eliceiri K. W.; White J. G.; Ramanujam N. In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 19494–19499. 10.1073/pnas.0708425104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walsh A. J.; Cook R. S.; Manning H. C.; Hicks D. J.; Lafontant A.; Arteaga C. L.; Skala M. C. Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. Cancer Res. 2013, 73, 6164–6174. 10.1158/0008-5472.CAN-13-0527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun N.; Xu H. N.; Luo Q.; Li L. Z. Potential indexing of the invasiveness of breast cancer cells by mitochondrial redox ratios. Adv. Exp. Med. Biol. 2016, 923, 121–127. 10.1007/978-3-319-38810-6_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu H. N.; Tchou J.; Feng M.; Zhao H.; Li L. Z. Optical redox imaging indices discriminate human breast cancer from normal tissues. J. Biomed. Opt. 2016, 21, 114003. 10.1117/1.JBO.21.11.114003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jentsch S.; Schweitzer D.; Schmidtke K.-U.; Peters S.; Dawczynski J.; Bär K.; Hammer M. Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer’s disease. Acta Ophthalmol. 2015, 93, e241–e247. 10.1111/aos.12609. [DOI] [PubMed] [Google Scholar]
- Xu H. N.; Gourmaud S.; Podsednik A.; Li X.; Zhao H.; Jensen F. E.; Talos D. M.; Li L. Z. Optical Redox Imaging of Ex Vivo Hippocampal Tissue Reveals Age-Dependent Alterations in the 5XFAD Mouse Model of Alzheimer’s Disease. Metabolites 2022, 12, 786. 10.3390/metabo12090786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walsh A. J.; Cook R. S.; Sanders M. E.; Aurisicchio L.; Ciliberto G.; Arteaga C. L.; Skala M. C. Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. Cancer Res. 2014, 74, 5184–5194. 10.1158/0008-5472.CAN-14-0663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shah A. T.; Heaster T. M.; Skala M. C. Metabolic imaging of head and neck cancer organoids. PLoS One 2017, 12, e0170415 10.1371/journal.pone.0170415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang T.; Zimmerley M. S.; Quinn K. P.; Lamarre-Jouenne I.; Kaplan D. L.; Beaurepaire E.; Georgakoudi I. Non-invasive monitoring of cell metabolism and lipid production in 3D engineered human adipose tissues using label-free multiphoton microscopy. Biomaterials 2013, 34, 8607–8616. 10.1016/j.biomaterials.2013.07.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen L.-C.; Lloyd W. R.; Kuo S.; Kim H. M.; Marcelo C. L.; Feinberg S. E.; Mycek M.-A. The potential of label-free nonlinear optical molecular microscopy to non-invasively characterize the viability of engineered human tissue constructs. Biomaterials 2014, 35, 6667–6676. 10.1016/j.biomaterials.2014.04.080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Venturas M.; Shah J. S.; Yang X.; Sanchez T. H.; Conway W.; Sakkas D.; Needleman D. J. Metabolic state of human blastocysts measured by fluorescence lifetime imaging microscopy. Hum. Reprod. 2022, 37, 411–427. 10.1093/humrep/deab283. [DOI] [PubMed] [Google Scholar]
- Venturas M.; Yang X.; Sakkas D.; Needleman D. Noninvasive metabolic profiling of cumulus cells, oocytes, and embryos via fluorescence lifetime imaging microscopy: a mini-review. Hum. Reprod. 2023, 38, 799–810. 10.1093/humrep/dead063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tan T. C. Y.; Mahbub S. B.; Campbell J. M.; Habibalahi A.; Campugan C. A.; Rose R. D.; Chow D. J. X.; Mustafa S.; Goldys E. M.; Dunning K. R. Non-invasive, label-free optical analysis to detect aneuploidy within the inner cell mass of the preimplantation embryo. Hum. Reprod. 2021, 37, 14–29. 10.1093/humrep/deab233. [DOI] [PubMed] [Google Scholar]
- Perez-Ramirez C. A.; Christofk H. R. Challenges in studying stem cell metabolism. Cell Stem Cell 2021, 28, 409–423. 10.1016/j.stem.2021.02.016. [DOI] [PubMed] [Google Scholar]
- Tan T. C.; Brown H. M.; Thompson J. G.; Mustafa S.; Dunning K. R. Optical imaging detects metabolic signatures associated with oocyte quality. Biol. Reprod. 2022, 107, 1014–1025. 10.1093/biolre/ioac145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Geyter C.; Wyns C.; Calhaz-Jorge C.; de Mouzon J.; Ferraretti A. P.; Kupka M.; Nyboe Andersen A.; Nygren K. G.; Goossens V. 20 years of the European IVF-monitoring Consortium registry: what have we learned? A comparison with registries from two other regions. Hum. Reprod. 2020, 35, 2832–2849. 10.1093/humrep/deaa250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chow D. J.; Wijesinghe P.; Dholakia K.; Dunning K. R. Does artificial intelligence have a role in the IVF clinic?. Reprod. Fertil. 2021, 2, C29–C34. 10.1530/RAF-21-0043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shiino A.; Haida M.; Beauvoit B.; Chance B. Three-dimensional redox image of the normal gerbil brain. Neuroscience 1999, 91, 1581–1585. 10.1016/S0306-4522(98)00670-8. [DOI] [PubMed] [Google Scholar]
- Masters B. R.; Kriete A.; Kukulies J. Ultraviolet confocal fluorescence microscopy of the in vitro cornea: redox metabolic imaging. Appl. Opt. 1993, 32, 592–596. 10.1364/AO.32.000592. [DOI] [PubMed] [Google Scholar]
- Santos Monteiro C. A.; Chow D. J.; Leal G. R.; Tan T. C.; Reis Ferreira A. M.; Thompson J. G.; Dunning K. R. Optical imaging of cleavage stage bovine embryos using hyperspectral and confocal approaches reveals metabolic differences between on-time and fast-developing embryos. Theriogenology 2021, 159, 60–68. 10.1016/j.theriogenology.2020.10.012. [DOI] [PubMed] [Google Scholar]
- Piston D.; Masters B.; Webb W. Three-dimensionally resolved NAD (P) H cellular metabolic redox imaging of the in situ cornea with two-photon excitation laser scanning microscopy. J. Microsc. 1995, 178, 20–27. 10.1111/j.1365-2818.1995.tb03576.x. [DOI] [PubMed] [Google Scholar]
- Georgakoudi I.; Quinn K. P. Label-Free Optical Metabolic Imaging in Cells and Tissues. Annu. Rev. Biomed. Eng. 2023, 25, 413–443. 10.1146/annurev-bioeng-071516-044730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weber M.; Huisken J. Light sheet microscopy for real-time developmental biology. Curr. Opin. Genet. Dev. 2011, 21, 566–572. 10.1016/j.gde.2011.09.009. [DOI] [PubMed] [Google Scholar]
- Walsh A. J.; Sharick J. T.; Skala M. C.; Beier H. T. Temporal binning of time-correlated single photon counting data improves exponential decay fits and imaging speed. Biomed. Opt Express 2016, 7, 1385–1399. 10.1364/BOE.7.001385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Favreau P. F.; He J.; Gil D. A.; Deming D. A.; Huisken J.; Skala M. C. Label-free redox imaging of patient-derived organoids using selective plane illumination microscopy. Biomed. Opt Express 2020, 11, 2591–2606. 10.1364/BOE.389164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hedde P. N.; Cinco R.; Malacrida L.; Kamaid A.; Gratton E. Phasor-based hyperspectral snapshot microscopy allows fast imaging of live, three-dimensional tissues for biomedical applications. Commun. Biol. 2021, 4, 721. 10.1038/s42003-021-02266-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lakowicz J. R.Principles of Fluorescence Spectroscopy; Springer, 2006. [Google Scholar]
- Schweitzer D.; Schenke S.; Hammer M.; Schweitzer F.; Jentsch S.; Birckner E.; Becker W.; Bergmann A. Towards metabolic mapping of the human retina. Microsc. Res. Tech. 2007, 70, 410–419. 10.1002/jemt.20427. [DOI] [PubMed] [Google Scholar]
- Sanchez T.; Venturas M.; Aghvami S. A.; Yang X.; Fraden S.; Sakkas D.; Needleman D. J. Combined noninvasive metabolic and spindle imaging as potential tools for embryo and oocyte assessment. Hum. Reprod. 2019, 34, 2349–2361. 10.1093/humrep/dez210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lagarto J. L.; Dyer B. T.; Talbot C. B.; Peters N. S.; French P. M.; Lyon A. R.; Dunsby C. Characterization of NAD (P) H and FAD autofluorescence signatures in a Langendorff isolated-perfused rat heart model. Biomed. Opt Express 2018, 9, 4961–4978. 10.1364/BOE.9.004961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang W. Q.; Sorvina A.; Morrison J. L.; Darby J. R. T.; Brooks D. A.; Plush S. E.; Afshar Vahid S. Development of an optical fiber-based redox monitoring system for tissue metabolism. J. Biophot. 2022, 15, e202100304 10.1002/jbio.202100304. [DOI] [PubMed] [Google Scholar]
- Fereidouni F.; Bader A. N.; Gerritsen H. C. Spectral phasor analysis allows rapid and reliable unmixing of fluorescence microscopy spectral images. Opt. Express 2012, 20, 12729–12741. 10.1364/OE.20.012729. [DOI] [PubMed] [Google Scholar]
- Pomeroy K. O.; Reed M. L. The effect of light on embryos and embryo culture. J. reproductive biotechnol. fertil. 2012, 3, 46–54. 10.1177/205891581200300203. [DOI] [Google Scholar]
- Punt-van der Zalm J.; Hendriks J.; Westphal J.; Kremer J.; Teerenstra S.; Wetzels A. Toxicity testing of human assisted reproduction devices using the mouse embryo assay. Reprod. Biomed. Online 2009, 18, 529–535. 10.1016/S1472-6483(10)60130-7. [DOI] [PubMed] [Google Scholar]
- Thompson J. G.; Brown H. M.; Sutton-McDowall M. L. Measuring embryo metabolism to predict embryo quality. Reprod. Fertil. Dev. 2016, 28, 41. 10.1071/RD15340. [DOI] [PubMed] [Google Scholar]
- Aoki F. Zygotic gene activation in mice: profile and regulation. J. Reprod. Dev. 2022, 68, 79–84. 10.1262/jrd.2021-129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vettenburg T.; Dalgarno H. I.; Nylk J.; Coll-Lladó C.; Ferrier D. E.; Čižmár T.; Gunn-Moore F. J.; Dholakia K. Light-sheet microscopy using an Airy beam. Nat. Methods 2014, 11, 541–544. 10.1038/nmeth.2922. [DOI] [PubMed] [Google Scholar]
- Bakas S.; Uttamchandani D.; Toshiyoshi H.; Bauer R. MEMS enabled miniaturized light-sheet microscopy with all optical control. Sci. Rep. 2021, 11, 14100–14111. 10.1038/s41598-021-93454-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hedde P. N. minispim—A miniaturized light-sheet microscope. ACS Sens. 2021, 6, 2654–2663. 10.1021/acssensors.1c00607. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The research data supporting this publication can be accessed at https://doi.org/10.17630/48ce8571-38bd-4c53-845a-5cfa2b89aa3a.







